GSK Plc has appointed Luke Miels as chief executive officer designate, as well as a member of the company’s board of directors, from 1 January 2026. Emma Walmsley, the current CEO who has led the company since 2017, will step down from her position. However she will remain with the business until her notice period ends on 30 September 2026.
